Trial Outcomes & Findings for Probiotics and Infections in Conscripts in Military Service (NCT NCT01651195)
NCT ID: NCT01651195
Last Updated: 2021-06-14
Results Overview
The number of sick days with respiratory and gastrointestinal symptoms and symptom incidence. Other outcome measures were the number and duration of infection episodes, the number of antibiotic treatments received, and the number of days out of service due to an infection. Respiratory infection episodes and symptomatic days were counted by the basis of respiratory infection symptoms recorded into the symptom diary and from the medical visits to health care centers. If the conscript showed minimum of two RTI symptoms for a period of one day or one RTI symptom for a period of two days a RTI episode was considered to be present. Between two episodes a minimum of seven days of non-symptomatic period should be experienced if to be considered as two separate infections. If there were less non-symptomatic days, it was considered to be a continuation of the same infection episode. Symptomatic days were days when at least one symptom was experienced.
COMPLETED
NA
983 participants
Through study completion, an average of 4 months
2021-06-14
Participant Flow
Sample size was calculated on the assumption that the use of probiotic would result in a 17% reduction in the number of sick days estimated that, with a power of 85% and at a significance level of 0.05 (Power 0.85, ß=0.15000 and α=0.05), we needed 300 conscripts per group to show a 17% difference between the groups. Each conscript was randomly allocated to the probiotic or the control group according to a computer generated, 8-blocked randomization list.
Participant milestones
| Measure |
Probiotic Tablet (Military Recruits)
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
Probiotic
|
Placebo Tablet (Military Recruits)
Chrystalline celluloce 2 x 2, 3 weeks
Placebo
|
Probiotic Tablet (Reserve Officer Candidates)
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
Probiotic
|
Placebo Tablet (Reserve Officer Candidates)
Chrystalline celluloce 2 x 2, 3 weeks
Placebo
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
284
|
284
|
204
|
211
|
|
Overall Study
COMPLETED
|
63
|
73
|
121
|
103
|
|
Overall Study
NOT COMPLETED
|
221
|
211
|
83
|
108
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Probiotic Tablet (Military Recruits)
n=284 Participants
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
Probiotic
|
Placebo Tablet (Military Recruits)
n=284 Participants
Chrystalline celluloce 2 x 2, 3 weeks
Placebo
|
Probiotic Tablet (Reserve Officer Candidates)
n=204 Participants
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
Probiotic
|
Placebo Tablet (Reserve Officer Candidates)
n=211 Participants
Chrystalline celluloce 2 x 2, 3 weeks
Placebo
|
Total
n=983 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=284 Participants
|
0 Participants
n=284 Participants
|
0 Participants
n=204 Participants
|
0 Participants
n=211 Participants
|
0 Participants
n=983 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
284 Participants
n=284 Participants
|
284 Participants
n=284 Participants
|
204 Participants
n=204 Participants
|
211 Participants
n=211 Participants
|
983 Participants
n=983 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=284 Participants
|
0 Participants
n=284 Participants
|
0 Participants
n=204 Participants
|
0 Participants
n=211 Participants
|
0 Participants
n=983 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=284 Participants
|
0 Participants
n=284 Participants
|
0 Participants
n=204 Participants
|
0 Participants
n=211 Participants
|
0 Participants
n=983 Participants
|
|
Sex: Female, Male
Male
|
284 Participants
n=284 Participants
|
284 Participants
n=284 Participants
|
204 Participants
n=204 Participants
|
211 Participants
n=211 Participants
|
983 Participants
n=983 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Finland
|
284 participants
n=284 Participants
|
284 participants
n=284 Participants
|
204 participants
n=204 Participants
|
211 participants
n=211 Participants
|
983 participants
n=983 Participants
|
PRIMARY outcome
Timeframe: Through study completion, an average of 4 monthsPopulation: According to the study nurse, the file containing number of sick days data of this particular study is no more available.
The number of sick days with respiratory and gastrointestinal symptoms and symptom incidence. Other outcome measures were the number and duration of infection episodes, the number of antibiotic treatments received, and the number of days out of service due to an infection. Respiratory infection episodes and symptomatic days were counted by the basis of respiratory infection symptoms recorded into the symptom diary and from the medical visits to health care centers. If the conscript showed minimum of two RTI symptoms for a period of one day or one RTI symptom for a period of two days a RTI episode was considered to be present. Between two episodes a minimum of seven days of non-symptomatic period should be experienced if to be considered as two separate infections. If there were less non-symptomatic days, it was considered to be a continuation of the same infection episode. Symptomatic days were days when at least one symptom was experienced.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Through study completion, an average of 4 monthsRespiratory infection episodes and symptomatic days were counted by the basis of respiratory infection symptoms recorded into the symptom diary and from the medical visits to health care centers.
Outcome measures
| Measure |
Probiotic Tablet (Military Recruits)
n=411 Episodes
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Military Recruits)
n=402 Episodes
Crystalline cellulose 2 x 2, 3 weeks
|
Probiotic Tablet (Reserve Officer Candidates)
n=56 Episodes
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Reserve Officer Candidates)
n=101 Episodes
Crystalline cellulose 2 x 2, 3 weeks
|
|---|---|---|---|---|
|
Number and Duration of Infection Episodes
|
33 Episodes
|
35 Episodes
|
30 Episodes
|
29 Episodes
|
SECONDARY outcome
Timeframe: Through study completion, an average of 4 monthsNumber of antibiotic treatments received were collected during the medical visits.
Outcome measures
| Measure |
Probiotic Tablet (Military Recruits)
n=91 Treatments
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Military Recruits)
n=88 Treatments
Crystalline cellulose 2 x 2, 3 weeks
|
Probiotic Tablet (Reserve Officer Candidates)
n=17 Treatments
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Reserve Officer Candidates)
n=31 Treatments
Crystalline cellulose 2 x 2, 3 weeks
|
|---|---|---|---|---|
|
Number of Antibiotic Treatments Received
|
15 Treatments
|
23 Treatments
|
2 Treatments
|
1 Treatments
|
SECONDARY outcome
Timeframe: Through study completion, an average of 4 monthsIf the conscript showed minimum of two RTI symptoms for a period of one day or one RTI symptom for a period of two days a RTI episode was considered to be present. Between two episodes a minimum of seven days of non-symptomatic period should be experienced if to be considered as two separate infections. If there were less non-symptomatic days, it was considered to be a continuation of the same infection episode. Symptomatic days were days when at least one symptom was experienced. Gastrointestinal tract infection episodes and symptom days were calculated in the same fashion except 14 non symptomatic days should be in between the two to be considered as two different episodes.
Outcome measures
| Measure |
Probiotic Tablet (Military Recruits)
n=150 Days
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Military Recruits)
n=150 Days
Crystalline cellulose 2 x 2, 3 weeks
|
Probiotic Tablet (Reserve Officer Candidates)
n=90 Days
Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks
|
Placebo Tablet (Reserve Officer Candidates)
n=90 Days
Crystalline cellulose 2 x 2, 3 weeks
|
|---|---|---|---|---|
|
Number of Days Out of Service Due to an Infection
|
44 Days
|
41 Days
|
4 Days
|
6 Days
|
Adverse Events
Probiotic Tablet (Military Recruits)
Placebo Tablet (Military Recruits)
Probiotic Tablet (Reserve Officer Candidates)
Placebo Tablet (Reserve Officer Candidates)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Prof. Anne Pitkäranta
Helsinki University Central Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place